Drugs Made In America Acquisition II Corp. (DMIIU) — 10-Q Filings
All 10-Q filings from Drugs Made In America Acquisition II Corp.. Browse 1 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (1)
-
DMIIU Raises $500M in IPO, Eyes Pharma Target Amidst Growing Deficit
— Nov 18, 2025 Risk: high
Drugs Made In America Acquisition II Corp. (DMIIU), a blank check company, reported a net loss of $46,158 for the three months ended September 30, 2025, and a n
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX